Zimmer Biomet Holdings generates $8.4B in annual revenue across 4 key segments: Hips ($2.1B), Knees ($3.4B), SET ($2.2B), and Technology And Data Bone Cement And Surgical ($687.4M). The company-wide operating margin is 14.02%. Based on the Q1 2026 filing.